azv

An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer
Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative …
PDF Cite Project DOI
An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer
Additional markers of response to anti-EGFR therapy in metastatic colon cancer: Morphological context matters
PDF Project Poster DOI
Identification of high risk patients in stage II pT3N0 microsatellite-stable colorectal cancer
PDF Project Poster DOI
QBI SABI 2023

The Spatial Analysis for Biological Imaging workshop.

Mar 27, 2023 1 min read
QBI SABI 2023
Clinical implications of intra-tumour heterogeneity in colon cancer
Region-based biomarkers.
Clinical implications of intra-tumour heterogeneity in colon cancer
Colobiome: Tumour-adjacent microbiome and immune profile of tumour in the context of heterogeneity and aggressivness of colorectal cancer
The aim is to improve prognostic and predictive stratification of CRC by defining microbial-immune-molecular CRC pathophenotypes and correlate them with tumour aggressiveness and patient prognosis.
Colobiome: Tumour-adjacent microbiome and immune profile of tumour in the context of heterogeneity and aggressivness of colorectal cancer